Tag: Dr. Reddy’s Laboratories
Mayne Pharma sells US retail generics portfolio for $134 million
Australian pharmaceutical manufacturing company Mayne Pharma has completed the sale of its US retail generics portfolio to Dr. Reddy’s Laboratories for approximately $134 million.
Featured Article
Manufacturing wrapped up: Key trends that defined the Australian industry in 2024
In 2024, Australia’s manufacturing sector showed incredible resilience and adaptability, proving why it’s such a vital part of the country’s economy.
